About Us
People
Insights
Publications
2024 Presidential Election
Cell and Gene
Inflation Reduction Act
Case Studies
Events
News
Videos
Solutions
Policy, Research, and Analysis
Market Access
Reimbursement
Strategic Analytics, Value and Economics
ADVI Databoard
Join Us
Get in Touch
Get in Touch
News
In The News
Dr. Michael Kolodziej considers value-based care and fee-for-service models
In The News
ADVI’s Dr. Kolodziej, Vice President and Chief Innovation Officer, Recognized for Outstanding Achievements
In The News
Rebecca Davison discusses Trump’s 2020 Budget with CNBC
In The News
ADVI’s Lindsay Bealor Greenleaf spoke with The Daily Caller about the future for ACA implementation, and how Congress may act to address rising Exchange premiums and deductibles
In The News
ADVI Director Lindsay Bealor Greenleaf talks to Bloomberg Law
In The News
ADVI director, Becca Davison, spoke with Morning Consult about defining value for pharmaceuticals and which factors are important to include in the process
In The News
ADVI Director, Lindsay Bealor Greenleaf, talked with CNBC about the Administration’s proposed rule on rebates and what it could mean for drug prices and PBMs
In The News
Director Lindsay Bealor Greenleaf discussed concerns regarding Medicare Part B step therapy with FierceHealthcare
In The News
ADVI’s Lindsay Bealor Greenleaf talks to Bloomberg Law about Drug Pricing Reform Expectations Under the 116th Congress
Posts pagination
< Previous page
1
…
17
18
19
…
24
Next page >